Lower Urinary Tract Symptoms (LUTS)
17
5
7
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.9%
1 terminated out of 17 trials
80.0%
-6.5% vs benchmark
12%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (17)
Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults
Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer
RCT on Running Water Sound During Urodynamic
Predictors of Trifecta Achievement After HoLEP
Genital Hygiene, Toilet Behaviors, and LUTS in Normal Weight and Obese Women
Study of Transition in Real-life Experiences Affecting Micturition and Well-being in Adolescent Years
Uroflowmetry Curve Types and IPSS in Men With LUTS
Reducing Disparities in Urinary Control Symptoms for Minority Women
Butterfly Pivotal Study
Safety and Effectiveness Study of the Zenflow Spring System
Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia and Ischemic Heart DIsease
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
Vesitirim™ in Men Postmarketing Observational Study